Fulvestrant Ever Pharma 250 mg Pre-filled Syringe — Hormone Therapy for Advanced Breast Cancer Fulvestrant Ever Pharma 250 mg Injection is a prescription oncology medication used in the treatment of estrogen receptor (ER)-positive locally advanced or metastatic breast cancer in postmenopausal women. Each pre-filled syringe contains 250 mg fulvestrant in 5 mL solution, designed for intramuscular administration by trained healthcare professionals. Fulvestrant works by binding to and degrading estrogen receptors on cancer cells, helping to slow tumour growth and improve clinical outcomes when used as monotherapy or with other agents such as palbociclib. Due to its potent effects and specific administration route, it is delivered in a clinical cancer-care setting with regular monitoring of liver function, blood counts, and patient response.